Gritstone bio Inc. (NASDAQ: GRTS) Stock Information | RedChip

Gritstone bio Inc. (NASDAQ: GRTS) Listen to this Section


$0.51
-0.0201 ( -3.79% ) 1.4M

Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.

Market Data


Open


$0.51

Previous close


$0.53

Volume


1.4M

Market cap


$59.07M

Day range


$0.50 - $0.58

52 week range


$0.45 - $3.33

Insider Ownership Transactions

Total Amount Purchased: -433,677.00 | $ -221,175.27

Date Type Amount Purchased Purchaser
2024-05-17 Sale -19149.00 Hawryluk Matthew
2024-05-17 Sale -27128.00 Economides Vassiliki
2024-05-17 Sale -10800.00 Cho James
2024-04-30 Sale -103600.00 Webster Stephen W
2024-02-05 Sale -18000.00 Cho James
2024-02-05 Sale -40000.00 Jooss Karin
2024-02-05 Sale -35000.00 Economides Vassiliki
2024-02-05 Sale -40000.00 Jones Erin
2024-02-05 Sale -35000.00 Hawryluk Matthew
2024-02-05 Sale -105000.00 Allen Andrew R

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 20, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
4 Insider transactions 1 May 17, 2024
10-q Quarterly Reports 80 May 09, 2024
8-k 8K-related 12 May 09, 2024
4 Insider transactions 1 Apr 30, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.